DPP-4 inhibitors on AARP Medicare Rx Preferred from UHC (S5921-407)
Januvia, Tradjenta and the other "gliptins" for type 2 diabetes, checked against this plan's 2026 formulary (its list of covered drugs).
- Plan type
- Stand-alone drug plan (PDP), New Mexico
- Premium
- $82.30/month
- Deductible
- $130.00, doesn't apply to tier 1 and 2
2 of 5 DPP-4 inhibitors are covered on this plan. None require prior authorization.
3 aren't on the formulary, including sitagliptin and saxagliptin.
- $18.76Tier 3
- $86.71Tier 3
Not on the formulary
sitagliptin, saxagliptin, alogliptin
Patient cost for a 30-day supply at a preferred retail pharmacy, after the $130.00 deductible where it applies. Where the plan charges a percentage (coinsurance), the dollar figure is that share of the plan's negotiated price; "from" means other strengths cost more. Data from the CMS 2026 Part D formulary and pricing files.